This year, BLOODPAC collaborated with the American Association for Cancer Research (AACR) to provide input on two important sessions that will be presented at the AACR Annual Meeting.

• What Defines the Gold Standard for Validating Blood-Based Cancer Early Detection Tests, will take place on Sunday, April 27th, from 1:00 to 2:30 PM CT, co-chaired by Christina Clarke Dur (GRAIL) and Bree Mitchell (Natera). 

• Modernizing Performance Statistics for Clinical Validation of Blood-Based Cancer Screening Tests, will be held on Tuesday, April 29th, from 4:00 to 5:30 PM CT, co-chaired by Phil Febbo (Veracyte) and Peter Kuhn (USC). 

If you are attending AACR, we invite you to join us!